KELLY MORGAN: Open Payments
NPI 1043804735 · NOVI, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,259 in 65 payments from 23 companies in 2025. Trend: 2023 $1,158 · 2024 $1,346 · 2025 $1,259
Food & beverage: $1,259
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 10 | $227 |
| ABBVIE INC. | 11 | $169 |
| Novo Nordisk Inc | 5 | $121 |
| Otsuka America Pharmaceutical, Inc. | 5 | $100 |
| E.R. Squibb & Sons, L.L.C. | 4 | $88 |
| Vanda Pharmaceuticals Inc. | 3 | $83 |
| Axsome Therapeutics, Inc. | 3 | $62 |
| Teva Pharmaceuticals USA, Inc. | 3 | $55 |
| Amgen Inc. | 3 | $50 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
Products named: REXULTI, VRAYLAR, COBENFY, FANAPT, Wegovy, Auvelity, UBRELVY, AUSTEDO XR.
Industry payments across MI — which companies pay providers there.
